The Global Hunt for Yield: Where Are the Best International Dividend Aristocrat Opportunities
Explore top international dividend aristocrats like Coloplast, NTT, and Roche, offering stability, growth, and reliable income for savvy investors
Hi StockOpiners,
It’s been a while since we featured a guest post, but today we have an exciting one for those interested in dividend stocks and international opportunities.
We’re pleased to welcome Max, the founder of MaxDividends.
Max is a private investor with a proven dividend growth strategy and a mission to help others build a reliable, steadily growing stream of passive income, perfect for anyone aiming to retire early and live off dividends. This article will give you a fresh perspective on finding high-quality dividend opportunities beyond US borders.
Intro
💡 Invest in companies you believe in - W. Buffett
For investors seeking stable sources of income, companies that consistently increase dividends represent an important segment of the portfolio. In this review, we will focus on international Dividend Aristocrats — companies that reliably pay and raise their dividends.
We will examine leaders such as Coloplast A/S, Nippon Telegraph & Telephone Corp, ASSA ABLOY AB (publ), Roche Holding AG, and Computershare Ltd. Each of these companies has strong financial positions, successful business models, and growth prospects, making them attractive to long-term investors.
1. Coloplast A/S (COLO-B)
Coloplast A/S develops and sells intimate healthcare products, including ostomy care, continence care, wound care, and respiratory care solutions. The company operates in several countries, including Denmark, the US, the UK, and France. It offers catheters, bowel irrigation systems, skin care products, and treatments for urological and gynecological conditions.
History of the Company
Coloplast A/S was founded in 1954, starting with an idea inspired by a personal experience. Elisa Sørensen, a nurse, came up with the world's first adhesive ostomy bag after her sister, Thora, had surgery to create a stoma and struggled with the fear of leakage when going out in public. Elisa, understanding the issue her sister faced, designed a solution. The idea was then developed further by civil engineer Aage Louis-Hansen and his wife, Joanna Louis-Hansen, a trained nurse, who created the first ostomy bag. This simple yet life-changing innovation helped Thora and thousands of others live fuller lives.
Today, Coloplast's product range has expanded to include ostomy care, continence care, skin and wound care, and urological products. The company employs over 10,000 people worldwide and continues to improve the quality of life for people with intimate health needs.
A Proven Dividend Aristocrat 🎩
Coloplast A/S is a proven Dividend Aristocrat, with a solid track record of consistently increasing its dividend payments over time. The company's 5-year dividend growth stands at 29%, and it has maintained dividend payouts for 30 consecutive years. The 5-year average payout ratio is 90%, demonstrating the company's commitment to returning value to its shareholders.
The projected 10-year dividend yield on cost (Max Ratio) is estimated at 4.81%, reflecting a strong potential for long-term dividend returns.
Financial Statement
If you want to stay on top of your portfolio's health, don't forget to check in on the financials of the companies you've invested in. The better shape they’re in, the better your results will be. Keep an eye on their quarterly and annual reports to see how they're performing.
Here is a quick dive into Coloplast A/S over last years
The strongest and most stable companies tend to have a Financial Score of 80+, with the very best ones hitting 90+. If you see that score start to dip below 80, that’s your cue to consider jumping ship before things get worse.
👉 Learn More about Financial Score
Our Paid Members get access to a curated watchlist of 19,000 companies worldwide, all scored by our team on a regular basis. Companies like Coloplast A/S are on that list, too.
Future Growth Prospects for Coloplast A/S.
FY 2024/25 guidance on organic growth of 8-9% and on EBIT margin before special items of around 28% unchanged.
With MaxDividends, it's easier than ever to access top dividend companies, track your results, and explore new dividend ideas.
The MaxDividends Top Stocks List features ~100 of the most reliable dividend companies in the U.S. market, each with 15+ years of consecutive dividend increases. These stocks are carefully selected based on MaxDividends' strict criteria for consistency and reliability.
Dividend Kings represent the elite tier of dividend growth stocks. With 50+ years of consecutive dividend increases, these companies offer unparalleled income stability, making them a top choice for investors seeking long-term reliability in an unpredictable market.
With 25+ years of consecutive dividend increases, Dividend Aristocrats are among the strongest dividend growth stocks. These companies have a proven track record of not only maintaining but consistently increasing their dividends, often outperforming the broader market over time.
2. Nippon Telegraph & Telephone Corp (9432)
Nippon Telegraph & Telephone Corp (NTT) is a major telecommunications company based in Japan. It operates through four main segments: Integrated ICT Business, Regional Communications Business, Global Solutions Business, and Others. NTT provides mobile services, domestic and international communications, cloud solutions, and IT system development. It also engages in real estate, energy, and other businesses.
History of the Company
Nippon Telegraph and Telephone Corporation (NTT) was founded in 1952 as a state-owned monopoly following the dissolution of Japan's previous government-operated telegraph and telephone services. The company became a key part of Japan's post-war telecommunications modernization. In 1985, the Japanese government initiated the privatization of NTT, leading to the company’s reorganization into several subsidiaries, including NTT East and NTT West. Full privatization was completed in 1999, and NTT was listed on the Tokyo Stock Exchange. NTT continued to expand its technological capabilities and, in 2020, became the first telecom company in the world to offer commercial 5G services. Today, NTT is one of the largest telecommunications companies globally, with revenues exceeding ¥12 trillion (about $112 billion) as of 2023.
A Proven Dividend Aristocrat 🎩
This company is a proven dividend champion with a Max Ratio of 7.39%, indicating an expected dividend yield on cost between 5-9% over the next 10 years. Over the past 5 years, the company has achieved a remarkable 37% dividend growth, with a consistent 21-year track record of paying dividends. Its 5-year average payout ratio is 24%, which suggests a balanced approach to returning profits to shareholders while retaining funds for reinvestment and growth.
Financial Statement
Here is a quick dive into Nippon Telegraph and Telephone Corporation over last years
Future Growth Prospects for Nippon Telegraph and Telephone Corporation.
The company is making significant investments in 5G technology, which is expected to be a major driver of growth, as the global 5G market is projected to grow exponentially. Additionally, NTT is expanding its cloud services, capitalizing on the rising demand for digital transformation across industries. The cloud computing market is anticipated to grow significantly in the coming years, further boosting NTT's revenue potential.
NTT's projected revenue for the fiscal year ending March 2024 is approximately ¥12 trillion ($110 billion), reflecting a 3.5% year-over-year growth, with operating income expected to increase to ¥1.25 trillion ($11.5 billion). The company is also focusing on strategic partnerships, such as its collaboration with Microsoft to enhance cloud solutions, and expanding its presence in emerging markets through local partnerships.
3. ASSA ABLOY AB (publ) (ASSA-B)
ASSA ABLOY AB (publ) is a global leader in security and access solutions, providing a wide range of products and services for institutional, commercial, and residential markets. The company specializes in door opening solutions, including electronic access control systems, mechanical products like locks and handles, and various types of doors. It also offers digital access solutions such as wireless and electronic key solutions, as well as building information modeling software. ASSA ABLOY operates under well-known brands like ASSA ABLOY, Yale, and HID, and serves various industries including aviation, healthcare, education, banking, and retail.
History of the Company
ABLOY was founded in 1907 when a young mechanic from Helsinki, Emil Henriksson, invented a unique locking mechanism based on rotating locking discs, which became the foundation for all ABLOY locks. In 1919, this invention was patented, and the company Ab Låsfabriken (later shortened to Ab Lukko Oy) was established in Helsinki. In 1923, Abloy was acquired by Kone & Siltarakennus, becoming part of the Wärtsilä Group. In 1994, the company merged with its Swedish competitor ASSA, forming ASSA ABLOY, which allowed it to become a global leader in security and access control solutions.
A Proven Dividend Aristocrat 🎩
ASSA ABLOY AB (publ) has shown a strong dividend track record with an estimated 10-year dividend yield on cost (Max Ratio) of 4.07%. The company has demonstrated impressive growth in its dividend payouts, with a 5-year dividend growth rate of 54% and a consistent dividend payout over 14 consecutive years. Its 5-year average payout ratio stands at 40%, indicating a balanced approach between rewarding shareholders and retaining earnings for reinvestment. This solid dividend history positions ASSA ABLOY as a proven dividend champion, making it an attractive option for long-term investors seeking reliable returns.
Financial Statement
Here is a quick dive into ASSA ABLOY AB over last years
Future Growth Prospects for ASSA ABLOY AB.
ASSA ABLOY is forecast to grow earnings and revenue by 9.3% and 6% per annum respectively. EPS is expected to grow by 9.3% per annum. Return on equity is forecast to be 15.5% in 3 years.
4. Roche Holding AG (RO)
Roche Holding AG is a global healthcare company based in Basel, Switzerland, founded in 1896. It operates in the pharmaceuticals and diagnostics sectors, offering solutions in areas such as oncology, ophthalmology, neurology, and respiratory disorders. The company provides in vitro tests for various diseases, including cancer and diabetes, along with digital health solutions. Roche is known for its innovative approach and strong market presence, focusing on both therapeutic products and diagnostic technologies worldwide.
History of the Company
Founded in 1896 in Basel, Switzerland, Roche Holding AG began as a pharmaceutical company focused on producing vitamin products. Over the years, it expanded its portfolio significantly, becoming one of the largest biotech companies in the world. By the end of 2022, Roche reported net sales of approximately 76.8 billion CHF. In the 1920s, Roche introduced its first major product, the sedative “Rocheval,” and by 1931, it established its first overseas subsidiary in Vienna, Austria. The company continued to grow internationally through significant acquisitions, such as the purchase of Genentech in 1990, which strengthened its biotechnology capabilities. Today, Roche maintains a robust pipeline of over 30 molecules in late-stage development, particularly in oncology, immunology, and neuroscience.
A Proven Dividend Aristocrat 🎩
The company has a stable dividend history with 28 consecutive years of payouts. The expected 10-year dividend yield is 3.67%, reflecting a combination of the current dividend yield and an average dividend growth rate of 10% over the past 5 years. The 5-year average payout ratio stands at 59%, indicating that the company consistently distributes around 59% of its profits as dividends. This makes the company an attractive option for long-term investors seeking steady returns.
Financial Statement
Here is a quick dive into Roche Holding AG over last years
Future Growth Prospects for Roche Holding AG.
Innovation is central to Roche's strategy, with the launch of new drugs like Risdiplam for spinal muscular atrophy. This product is expected to generate CHF 2 billion in sales by 2025. Additionally, Roche is expanding into emerging markets, particularly in the Asia-Pacific region, where it saw a 15% increase in revenue in 2023, contributing around CHF 5 billion to total sales.
Acquisitions, such as the purchase of Spark Therapeutics for USD 4.8 billion, are also fueling growth. This acquisition strengthens Roche’s presence in gene therapy and is expected to add CHF 1.5 billion in sales by 2024. With over 40 candidates in its pipeline, Roche is set to drive revenue growth, projected at a 4-5% compound annual growth rate (CAGR) through 2025.
Strategic partnerships, including collaborations with Regeneron for the antibody drug Dupixent, are expected to contribute approximately USD 10 billion in combined revenues by 2025. Roche’s commitment to R&D, with CHF 12.5 billion spent in 2022, positions the company at the forefront of innovation in the biopharmaceutical sector.
5. Computershare Ltd. (CPU)
Computershare Ltd. is a global financial services company that specializes in providing a wide range of services, including issuer services (such as register maintenance and corporate governance), corporate trust, employee share plans, mortgage and property rental services, communication services, and technology solutions. The company operates across various international markets, including Australia, Hong Kong, the UK, and Canada. Established in 1978, Computershare is known for its expertise in capital markets and is recognized for its strong financial performance and commitment to sustainability.
History of the Company
Computershare Ltd. was founded in 1978 in Melbourne, Australia, as one of the city's first start-up technology companies. Initially, the company focused on providing computer services to businesses that needed to automate processes. Over time, it transitioned to offering specialized computer bureau services to Australian share registrars, where it quickly excelled. By 1994, the company went public on the Australian Securities Exchange (ASX), with a market capitalization of AUD 36 million. From there, Computershare expanded globally, acquiring successful companies and growing organically. Today, it operates in multiple countries, managing over 75 million customer records and employing more than 12,000 people worldwide. Through its strategic growth in areas such as employee equity plans, corporate governance, and mortgage services, Computershare has become a leading player in the financial services industry.
A Proven Dividend Aristocrat 🎩
Computershare Ltd. is a proven dividend champion, demonstrating a strong commitment to returning value to its shareholders. The company's Max Ratio indicates an expected 5-9% dividend yield on cost over the next 10 years, reflecting its solid financial standing. With a remarkable 88% growth in the last 5 years, it has maintained a consistent dividend track record for 11 consecutive years. The 5-year average payout ratio stands at 106%, showcasing the company's dedication to rewarding its investors despite its growing business.
Financial Statement
Here is a quick dive into Computershare Ltd. over last years
Future Growth Prospects for Computershare Ltd.
Computershare is forecast to grow earnings and revenue by 7.2% and 1.5% per annum respectively. EPS is expected to grow by 7.6% per annum. Return on equity is forecast to be 40.5% in 3 years.
Final Thoughts
International dividend aristocrats, like Coloplast, NTT, ASSA ABLOY, Roche, and Computershare, are companies with a history of stable and growing dividends. They have strong businesses, sound finances, and growth prospects. Investors looking for reliable income and long-term capital growth should pay attention to them. These are just a few examples, but they demonstrate that international dividend companies are an attractive option for an investment portfolio.
To your wealth, MaxDividends Team
Thank you for reading Max’s work today. We hope it offered valuable insights and helped expand your investment horizon.